Current position
Inserm Research Director
Group leader, Institut du Fer à Moulin, UMR-S 839, Inserm, UPMC
Previous positions
2003-2007 Inserm Research Associate, UMR-739 (Dr. Richard Miles), Inserm, Pitié-Salpêtrière Hospital, Paris
1999-2003 Inserm Research Associate, UMR-8118 (Dr. Alain Marty), CNRS, Paris-Descartes University, Paris
1997-1999 Postdoctoral fellow, Cold Spring Harbor Laboratory (Dr. Roberto Malinow), New York, USA
1994-1996 Graduate student, Brain Research Institute (Pr. Beat Gähwiler), University of Zurich, Switzerland
1992-1997 Graduate student, Lab. Neurobiologie Cellulaire (Dr. henri Korn), Institut Pasteur, Paris
1991 Undergraduate, Lab. Neurobiologie (Pr. Philippe Ascher), Ecole Normale Supérieure, Paris
Education
2006 Habilitation (HDR), Pierre & Marie Curie University, Paris
1997 Ph.D. in Molecular and Cellular Pharmacology, Pierre & Marie Curie University, Paris
1992 Master in Molecular and Cellular Biology, Claude Bernard Univ. & Ecole Normale Supérieure, Lyon
1989 B.Sc. in Life and Earth Sciences (major), Claude Bernard University, Lyon
1987 Baccalaureate (Mathematics and Physics), Lycée Vauvenargues, Aix-en-Provence
Honors and Awards
2014 Fondation pour la Recherche Médicale research grant (Equipe FRM)
2013 Human Frontier Science Program research grant
2008 Agence Nationale de la Recherche research grant
2008 Biomedical and health research grant, City of Paris
2006 Inserm Avenir program grant
2003 Electricité de France research grant
2002 Fondation pour la Recherche Médicale, Young team support grant
2000 CNRS, Young team support grant
1997 Human Frontier Science Program long term fellowship
1994 European Commission, Marie Curie fellowship
1992 Ministry of Research and Space doctoral fellowship
Scientific boards and community
2012- Review Editor, Frontiers in Synaptic Neuroscience
2008- Scientific board, PhD program ‘Brain, Cognition & Behavior’. Pierre & Marie Curie Univ.
2003-2007 Editorial board of the Lettre des Neurosciences, a publication of the Société des Neurosciences
1999-2004 Bureau des Jeunes Chercheurs (Société des Neurosciences)
Learned Societies
1998- Society for Neuroscience (USA)
1992- Société des Neurosciences (France)
Teaching
2007-2011 Master in Biology, Lecture on Synaptic plasticity in the hippocampus, Ecole Normale Supérieure, Cachan
2004-present Master in Integrative Biology & Physiology, Neuroscience. Lectures on Synaptic and Cellular Plasticity. Pierre & Marie Curie University, Paris
2000-2002 Master in Medical and Biological Sciences. Lecture on Physiological and genetic approaches to epilepsy. Pierre & Marie Curie University, Paris
1999-2000 Master in Neuropharmacology. Lecture on Synaptic plasticity, Ecole Normale Supérieure / Pierre & Marie Curie University, Paris
Cortical GABAergic interneurons play a critical role in shaping the activity of neuronal ensembles. In particular, in the hippocampus, GABA signaling is involved in the maintenance of rhythmic population activities associated with various behavioral states and cognitive tasks.
However, even a partial reduction in GABAergic transmission leads to an anomalous synchronization of neuronal activity and the emergence of epileptiform discharges.
Our objective is to identify the alterations of GABAergic networks responsible for the initiation and maintenance of epileptiform activities in the hippocampal network. Specifically, we combine cellular electrophysiology and molecular imaging techniques to examine:
- the functional impact of human mutations affecting GABA signaling and associated with idiopathic generalized epileptic syndromes,
- the long term changes in hippocampal GABAergic circuits initiated by a period of epileptiform activity,
- the perturbations of chloride homeostasis induced in several pathological conditions, and their long term effects on synaptic transmission in cortical networks,
- the emergence and the functional consequences of the transient GABAergic phenotype of newborn dentate gyrus granule cells induced upon seizures.
Our work aims at better understanting the consequences of seizures and identify putative targets for novel therapeutical approaches.